Pembrolizumab for locally advanced cervical cancer - Authors' reply

Lancet. 2024 Nov 23;404(10467):2051-2052. doi: 10.1016/S0140-6736(24)02232-3.

Authors

Domenica Lorusso¹, Karin Yamada², Kan Li², Annamaria Cerrotta³, Gabriella Macchia⁴

Affiliations

¹ Gynaecological Oncology Medical Unit, Humanitas Hospital San Pio X, Milan 20159, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy. Electronic address: domenica.lorusso@hunimed.eu.
² Merck, Rahway, NJ, USA.
³ Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
⁴ Radiation Oncology Unit, Responsible Research Hospital, Campobasso, Molise, Italy.

PMID: 39580201
DOI: 10.1016/S0140-6736(24)02232-3

No abstract available

Publication types

Letter